SCHEMBL214484

SCHEMBL214484

Cc1cc(N)ccc1N(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
PDE10A Q9Y233 1/20 0.48
CASP1 P29466 3/20 0.46
CYP3A4 P08684 3/20 0.43
TSHR P16473 2/20 0.43
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42
TP53 P04637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 4/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 3/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 3/20 0.42
MEN1 O00255 2/20 0.42
THRB P10828 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ESR1 P03372 1/20 0.40
CHEK1 O14757 1/20 0.39
NEK2 P51955 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9788675 0.98 ALDH1A1 (0.52) ALDH1A1PDE10ACASP1CYP3A4TSHR
Hydrochloric Acid SCHEMBL9788673 0.98 ALDH1A1 (0.52) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL11824560 0.82 ALDH1A1 (0.50) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL865227 0.81 ALDH1A1 (0.54) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL11811790 0.80 CYP3A4 (0.46) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL7406313 0.78 GAA (0.59) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL10956325 0.78 ALDH1A1 (0.44) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL526857 0.76 ALDH1A1 (0.48) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL28512183 0.76 ALDH1A1 (0.43) ALDH1A1PDE10ACASP1CYP3A4TSHR
SCHEMBL15958221 0.76 L3MBTL1 (0.52) ALDH1A1PDE10ACASP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3096735-A1 GRADUAL HAIRCOLOR COMPOSITIONS AND METHODS OF USING THE SAME Combe International Ltd. (US) 2016-11-30 EP claimed
CN-105916482-A Gradual hair color compositions and methods of use thereof 酷姆国际公司 2016-08-31 CN claimed
WO-2015112789-A1 GRADUAL HAIRCOLOR COMPOSITIONS AND METHODS OF USING THE SAME COMBE INTERNATIONAL LTD. (US) 2015-07-30 WO claimed
CN-101229106-B Dye composition of acidic ph comprising 2,3-diamino-6,7-dihydro-1h,5h-pyrazolo[1,2-a]pyrazol-1-one, a para- phenylenediamine, a meta-aminophenol and an oxidizing agent OREAL 2013-04-10 CN claimed
WO-2011111054-A1 IMPROVED HAIR DYE COMPOSITION CAVINKARE PVT. LTD, (IN) 2011-09-15 WO claimed
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS SYNTA PHARMACEUTICALS CORPORATION (US) 2010-10-07 US claimed
EP-2175830-A2 COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES L'Oreal (FR) 2010-04-21 EP claimed
WO-2009016061-A2 COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES L'OREAL (FR) 2009-02-05 WO claimed
EP-1819341-A2 IL-12 MODULATORY COMPOUNDS Synta Pharmaceuticals Corporation (US) 2007-08-22 EP claimed
US-20060223996-A1 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2006-10-05 US claimed
WO-2006053227-A2 IL-12 MODULATORY COMPOUNDS SYNTA PHARMACEUTICALS CORP. (US) 2006-05-18 WO claimed
US-6004356-A HAIR DYES L'OREAL (FR) 1999-12-21 US claimed
EP-4395734-A1 COMPOSITIONS, KITS, AND METHODS FOR ALTERING THE COLOR OF HAIR L'OREAL (FR) 2024-07-10 EP disclosed
EP-4362902-A1 COMPOSITIONS CONTAINING DIRECT DYES FOR IMPARTING COLOR AND TONE TO THE HAIR L'OREAL (FR) 2024-05-08 EP disclosed
EP-4362906-A1 COMPOSITION COMPRISING SHEA, AN ALKYL(POLY)GLYCOSIDE, A POLYSACCHARIDE AND A DYE L'OREAL (FR) 2024-05-08 EP disclosed
EP-4362889-A1 COMPOSITION COMPRISING AT LEAST ONE OXIDATION DYE, 1,3-PROPANEDIOL, AT LEAST ONE ALKALINE AGENT AND AT LEAST ONE FATTY SUBSTANCE L'OREAL (FR) 2024-05-08 EP disclosed
US-4195998-A NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, QUINONE OR CARBAZIDE PHOTOREDUCTANT EASTMAN KODAK COMPANY (US) 1980-04-01 US disclosed
US-4182886-A OPTICAL FILTERS IN COLOR PHOTOGRAPHY CIBA-GEIGY AKTIENGESELLSCHAFT (CH) 1980-01-08 US disclosed
US-3976491-A DIAZONIUM SALT, DIHYDROXYBENZENE COUPLER SCOTT PAPER COMPANY (US) 1976-08-24 US disclosed
US-3971663-A CYANOACETAMIDO NAPHTHALENES OCE-BRUNING, INC. A CORP. OF DELAWARE 1976-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223996-A1 IL-12 modulatory compounds IL2, IL4, IFNG ALDH1A1 1381/4885PDE10A 929/4885CASP1 231/4885
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS IL2, IL4, IFNG ALDH1A1 1381/4885PDE10A 929/4885CASP1 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.